Physician profile
Scott Bradley
NPI 1346355351
$3,292.31
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $590 · 2021: $255 · 2022: $722 · 2023: $1,453 · 2024: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120 · Consulting Fee: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,120.41 |
| Consulting Fee | $605.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $743.11 | 2021-2024 | Floseal |
| Ethicon INC. | $605.00 | 2023 | Stratafix, Prolene, Vicryl |
| Paragonix Technologies, INC. | $343.68 | 2022-2023 | Paragonix Sherpapak Cardiac Transport System, Sherpacool Box, Shipper Box |
| Abbott Laboratories | $339.32 | 2019-2022 | |
| Livanova USA, INC. | $260.67 | 2019 | |
| Zimmer Biomet Holdings, INC. | $249.72 | 2019-2022 | |
| Clearflow INC. | $191.60 | 2023 | Pleuraflow System With Flowglide |
| Corcym INC | $139.29 | 2023 | Perceval |
| Avanos Medical | $136.07 | 2021 | |
| Kls-Martin L.P. | $101.53 | 2023 | |
| Smith+Nephew, INC. | $100.50 | 2024 | Renasys Touch, Pico |
| Atricure, INC. | $59.13 | 2024 | |
| Ethicon US, LLC | $22.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.